RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Bausch Health Companies Stock

Bausch Health Companies Liabilities 2024

Bausch Health Companies Liabilities

28.37 B USD

Ticker

BHC.TO

ISIN

CA0717341071

WKN

A2JQ1X

In 2024, Bausch Health Companies's total liabilities amounted to 28.37 B USD, a 7.56% difference from the 26.38 B USD total liabilities in the previous year.

Bausch Health Companies Aktienanalyse

What does Bausch Health Companies do?

Bausch Health Companies Inc is a Canadian pharmaceutical company that was founded in 2013. However, the company's history dates back to 1853 when John Jacob Bausch and Henry Lomb founded their own company in the USA. This company specialized in optical products, particularly eyeglass frames and lenses. Over the years, the company expanded its product range and also became involved in the production of contact lenses in the 1960s. In the 1970s, the company began to focus on the medical devices sector and expanded in this area through various acquisitions. In the 1990s, the company also established itself in the pharmaceutical sector by building various channels for the distribution of medications. In 2013, the company was renamed and restructured due to financial problems, and in the future, it operated under the name Bausch Health Companies Inc. The company's business model is based on the development, manufacture, and marketing of products in the medical and ophthalmology fields. The company works closely with various institutions such as doctors, pharmacies, and hospitals to ensure that its products are used optimally. The company operates in various areas, including: - Ophthalmology: Bausch Health Companies offers various products in the field of ophthalmology, including contact lenses, eye drops, and other medications that can be used to treat eye diseases such as cataracts or glaucoma. - Dermatology: The company also develops and markets products in the field of dermatology, including medications for the treatment of acne, rosacea, and psoriasis. - Gastroenterology: Bausch Health Companies also produces medications for the treatment of gastrointestinal diseases, such as medications for ulcers or inflammatory bowel diseases. - Neurology: The company manufactures medications for the treatment of neurological disorders, such as epilepsy or migraines. - Urology: Bausch Health Companies also offers products in the field of urology, including medications for the treatment of urinary tract infections or bladder problems. One of the most well-known products of Bausch Health Companies is the brand Bausch + Lomb, which operates in the field of ophthalmology and offers various contact lenses and eye drops. Another well-known product is Jublia, a medication for nail fungus. Overall, Bausch Health Companies is a leading company in the field of medicine and ophthalmology with a long history. With its diverse range of medications and products, it offers effective and reliable solutions for the treatment of various conditions to patients worldwide. Bausch Health Companies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Bausch Health Companies's Liabilities

Bausch Health Companies's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Bausch Health Companies's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Bausch Health Companies's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Bausch Health Companies's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Bausch Health Companies’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Bausch Health Companies stock

What is the level of liabilities of Bausch Health Companies this year?

Bausch Health Companies has a debt balance of 28.37 B USD this year.

What were the liabilities of Bausch Health Companies compared to the previous year?

The liabilities of Bausch Health Companies have increased by 7.56% increased compared to the previous year.

What are the consequences of high debt for investors of Bausch Health Companies?

High liabilities can pose a risk for investors of Bausch Health Companies, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Bausch Health Companies?

Low liabilities mean that Bausch Health Companies has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Bausch Health Companies affect the company?

An increase in liabilities of Bausch Health Companies can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Bausch Health Companies affect the company?

A decrease in the liabilities of Bausch Health Companies can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Bausch Health Companies?

Some factors that can influence the liabilities of Bausch Health Companies include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Bausch Health Companies so important for investors?

The liabilities of Bausch Health Companies are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Bausch Health Companies take to modify the liabilities?

To change its liabilities, Bausch Health Companies can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Bausch Health Companies pay?

Over the past 12 months, Bausch Health Companies paid a dividend of 1.28 USD . This corresponds to a dividend yield of about 15.92 %. For the coming 12 months, Bausch Health Companies is expected to pay a dividend of 0 USD.

What is the dividend yield of Bausch Health Companies?

The current dividend yield of Bausch Health Companies is 15.92 %.

When does Bausch Health Companies pay dividends?

Bausch Health Companies pays a quarterly dividend. This is distributed in the months of April, June, September, December.

How secure is the dividend of Bausch Health Companies?

Bausch Health Companies paid dividends every year for the past 6 years.

What is the dividend of Bausch Health Companies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Bausch Health Companies located?

Bausch Health Companies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bausch Health Companies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bausch Health Companies from 12/22/2010 amounting to 1 USD, you needed to have the stock in your portfolio before the ex-date on 11/10/2010.

When did Bausch Health Companies pay the last dividend?

The last dividend was paid out on 12/22/2010.

What was the dividend of Bausch Health Companies in the year 2023?

In the year 2023, Bausch Health Companies distributed 0 USD as dividends.

In which currency does Bausch Health Companies pay out the dividend?

The dividends of Bausch Health Companies are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Bausch Health Companies stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Bausch Health Companies

Our stock analysis for Bausch Health Companies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bausch Health Companies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.